Nurse Practitioner, Family · Eugene, OR
NPI
1912353657
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1488 Oak St
Eugene, OR, 97401
Phone (541) 683-1577
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
1,940 services
Medicare patients, 2024
207
Average age 70
Drug cost, 2024
$1.7M
2,397 prescriptions
Company payments, 2025
$514
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melanie Wayne was code 95004 (test - miscellaneous), 436 times for 23 patients. In total Melanie Wayne billed 1,940 services in 29 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 436 | 23 | $2.23 | $972 |
| 95115 Treatment - Miscellaneous | Office | 292 | 19 | $5.27 | $1,540 |
| 99214 Office E&M - Established | Office | 237 | 157 | $69.07 | $16K |
| 95165 Treatment - Miscellaneous | Office | 186 | 21 | $8.95 | $1,665 |
| 95117 Treatment - Miscellaneous | Office | 129 | 12 | $6.64 | $857 |
| 94010 Pulmonary Function Testing | Office | 56 | 48 | $16.07 | $900 |
| 99204 Office E&M - New | Office | 49 | 49 | $101.61 | $4,979 |
| 95012 Pulmonary | Office | 15 | 13 | $10.72 | $161 |
| G0009 Administration of pneumococcal vaccine | Office | 13 | 13 | $31.25 | $406 |
| 90677 Vaccine Product | Office | 11 | 11 | $290.41 | $3,195 |
By year: 2022 $32K for 1,912 services; 2023 $34K for 1,730 services; 2024 $45K for 1,940 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melanie Wayne prescribed most often to Medicare patients was Montelukast Sodium, with 224 prescriptions and refills. In total Melanie Wayne wrote 2,397 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 224 | 522 | 64 | $3,012 |
| Azelastine Hcl Generic | 193 | 230 | 80 | $4,597 |
| Pantoprazole Sodium Generic | 165 | 299 | 46 | $2,219 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 162 | 177 | 69 | $4,649 |
| Famotidine Generic | 146 | 263 | 41 | $2,768 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 136 | 199 | 31 | $125K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 105 | 170 | 32 | $19K |
| Fluticasone Propionate Generic | 82 | 111 | 20 | $3,948 |
| Spiriva Respimat Tiotropium Bromide | 79 | 97 | 23 | $43K |
| Qvar Redihaler Beclomethasone Dipropionate | 55 | 76 | 19 | $17K |
| Ipratropium Bromide Generic | 54 | 108 | 28 | $1,729 |
| Symbicort Budesonide/Formoterol Fumarate | 49 | 61 | 13 | $13K |
| Breo Ellipta Fluticasone/Vilanterol | 48 | 66 | Under 11 | $26K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 46 | 68 | 19 | $15K |
| Omeprazole Generic | 43 | 83 | 12 | $1,157 |
Brand drugs: 967 claims; generic drugs: 1,430 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melanie Wayne $514 ($514 in general payments such as food, travel and fees) from 10 companies. The largest payer was Blueprint Medicines Corporation with $131.
| Company | Payments | Amount |
|---|---|---|
| Blueprint Medicines Corporation SNY | 1 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $96.89 |
| GlaxoSmithKline, LLC. GSK | 2 | $55.94 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $53.75 |
| CSL Behring CSL.AX | 3 | $49.22 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $33.52 |
| BioCryst US Sales Co., LLC | 1 | $30.31 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $25.99 |
| TerSera Therapeutics LLC | 1 | $19.67 |
| Genzyme Corporation SNY | 1 | $17.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.